US Stock MarketDetailed Quotes
ME 23andMe
- 0.369
- +0.022+6.19%
Close Oct 1 16:00 ET
186.72MMarket Cap-281P/E (TTM)
0.372High0.345Low3.62MVolume0.345Open0.348Pre Close1.32MTurnover1.09%Turnover RatioLossP/E (Static)506.01MShares1.02052wk High1.30P/B122.67MFloat Cap0.29052wk Low--Dividend TTM332.45MShs Float18.160Historical High--Div YieldTTM7.80%Amplitude0.290Historical Low0.364Avg Price1Lot Size
About 23andMe Company
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in Sunnyvale, CA.
Company Profile
SymbolME
Company Name23andMe
Listing DateJun 17, 2021
Founded2006
CEOMs. Anne Wojcicki
MarketNASDAQ
Employees582
Fiscal Year Ends03-31
Address223 North Mathilda Avenue
CitySunnyvale
ProvinceCalifornia
CountryUnited States of America
Zip Code94086
Phone1-650-938-6300
Websitehttp://www.23andme.com
Company Executives
- Name
- Position
- Salary
- Anne Wojcicki
- Chief Executive Officer, President and Chairman of the Board
- 7.36M
- Joseph Anthony Selsavage
- Chief Financial Officer and Chief Accounting Officer
- 2.13M
- Guy Chayoun
- Vice President, Interim General Counsel and Corporate Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
